Oriol Pares
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Post-SABR early PSA density kinetics in androgen deprivation therapy-naïve patients: early landmark models for long-term biochemical recurrence-free survival.
Journal: Clinical and translational radiation oncology
Published: May 31, 2026
Partial Responders to Neoadjuvant Therapy and the Risk of Distant Metastases: Longer Intervals to Definitive Resection Is Not a Risk Factor.
Journal: Diseases of the colon and rectum
Published: June 17, 2025
Local Regrowth and the Risk of Distant Metastases Among Patients Undergoing Watch-and-Wait for Rectal Cancer: What Is the Best Control Group? Multicenter Retrospective Study.
Journal: Diseases of the colon and rectum
Published: July 26, 2023
Watch and Wait for rectal cancer in inflammatory bowel disease.
Journal: BMJ case reports
Published: July 10, 2023
Author response to: Comment on: Outcomes following watch and wait of a clinical complete response in rectal cancer after neoadjuvant treatment: comparison of patients with and without complete response at first reassessment in the International Watch & Wait Database (IWWD).
Journal: The British journal of surgery
Published: May 23, 2023
Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
Journal: The British journal of surgery
Published: October 28, 2022
Health-related quality of life of salvage prostate reirradiation using stereotactic ablative radiotherapy with urethral-sparing.
Journal: Frontiers in oncology
Published: July 02, 2022
Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study.
Journal: Diagnostic and prognostic research
Published: March 11, 2022
Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase II Study.
Journal: Frontiers in oncology
Published: January 27, 2022
Zebrafish Avatars of rectal cancer patients validate the radiosensitive effect of metformin.
Journal: Frontiers in oncology
Published: January 26, 2022
cT2N0 Distal Rectal Cancer: Do Not Believe in Fairy Tales.
Journal: Diseases of the colon and rectum
Published: November 14, 2021
Last Updated: 09/26/2026